Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok3. fázis

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

A legfontosabb adatok

Hol
Anaheim, Atlanta, Austin, Boston, Brooklyn, Charleston, Chicago, Cranston, Cromwell, Dallas, Duncansville, Glendale, Hartsdale, Hazelwood, High Point, Hollywood, Houston, Huber Heights, Jacksonville, Kansas City, Knoxville, Lakeland, Las Vegas, Little Rock, Louisville, Maitland, Marietta, Memphis, Milford, Norcross, North Dartmouth, Oceanside, Orlando, Overland Park, Phoenix, Plymouth Meeting, Prairieville, Prosper, Redlands, Rockville, Sacramento, San Antonio, Santa Ana, Springfield, Tampa, The Villages, The Woodlands, Tinley Park, Town and Country, Tucson, Tulsa, Watertown és Williamsville (Egyesült Államok)Mind a 53 helyszín megnézése
Fázis
3. fázis

Helyszínek itt: Egyesült Államok

  • Anaheim, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Atlanta, GeorgiaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Austin, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Boston, MassachusettsHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Brooklyn, New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Charleston, South CarolinaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Chicago, IllinoisHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Cranston, Rhode IslandHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Cromwell, ConnecticutHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Dallas, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Duncansville, PennsylvaniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Glendale, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Hartsdale, New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Hazelwood, MissouriHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • High Point, North CarolinaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Hollywood, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Huber Heights, OhioHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Jacksonville, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Kansas City, KansasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Knoxville, TennesseeHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Lakeland, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Las Vegas, NevadaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Little Rock, ArkansasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Louisville, KentuckyHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Maitland, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Marietta, GeorgiaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Memphis, TennesseeHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Milford, OhioHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Norcross, GeorgiaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • North Dartmouth, MassachusettsHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Oceanside, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Orlando, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Overland Park, KansasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Phoenix, ArizonaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Plymouth Meeting, PennsylvaniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Prairieville, LouisianaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Prosper, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Redlands, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Rockville, MarylandHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Sacramento, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • San Antonio, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Santa Ana, CaliforniaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Springfield, MassachusettsHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Tampa, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • The Villages, FloridaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • The Woodlands, TexasHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Tinley Park, IllinoisHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Town and Country, MissouriHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Tucson, ArizonaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Tulsa, OklahomaHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Watertown, MassachusettsHospital not named in the registryContact: Study DirectorRésztvevőt keres
  • Williamsville, New YorkHospital not named in the registryContact: Study DirectorRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Axsome Therapeutics, Inc.
Azonosító
NCT07398417
A regiszteradat frissítve
2026. november 10.
Eredeti leírás
The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.A teljes eredeti leírásKevesebb

A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy and Safety of AXS-14 in the Management of Fibromyalgia

The study is a Phase 3, double-blind, placebo-controlled, randomized withdrawal study to assess the efficacy and safety of AXS-14 in the management of fibromyalgia.

Bevonási feltételek: Has a primary diagnosis of fibromyalgia based on the 2016 ACR diagnostic criteria; Male or female, ≥18 years of age; Provides written informed consent to participate in the study before conducting any study procedures.

Kizáró feltételek: Previous participation in a clinical trial with reboxetine or esreboxetine or currently receiving treatment with reboxetine for any condition; Unable to comply with study procedures; Medically inappropriate for study participation in the opinion of the investigator.

ClinicalTrials.gov NCT07398417